WORCESTER, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTC:ACTC) announced today that its technology platform, which utilizes a single cell biopsy that does not destroy the embryo, is well positioned to receive Federal funding under the new administration led by President-Elect Barrack Obama. The Company has the only technology that can produce stem cell lines of all types without the destruction of the embryo. Funding of these types of technologies is expected to be a high priority of the incoming Administration.
